Multicentre laboratory validation of the colorimetric redox indicator (CRI) assay for the rapid detection of extensively drug-resistant (XDR) Mycobacterium tuberculosis

Journal of Antimicrobial Chemotherapy

Volumn 66, Issue 4, 2011, Pages 827-833

  Martin, Anandi ^a   Paasch, Fabienne ^a   Docx, Sven ^a   Fissette, Krista ^a   Imperiale, Belen ^b   Ribón, Wellman ^c,d   González, Liliana Andrea ^d   Werngren, Jim ^e   Engström, Anna ^e,f   Skenders, Girts ^g   Juréen, Pontus ^e   Hoffner, Sven ^e   Del Portillo, Patricia ^h   Morcillo, Nora ^b   Palomino, Juan Carlos ^a  

^a INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^b Hospital Zonal de Agudos y Cronicos Dr Antonio A Cetrangolo   (Argentina)

^c INSTITUTO NACIONAL DE SALUD   (Colombia)

^d UNIVERSIDAD INDUSTRIAL DE SANTANDER   (Colombia)

^e SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^f KAROLINSKA INSTITUTE   (Sweden)

^g Clinic of Tuberculosis and Lung Diseases   (Latvia)

^h Genomics and Evolution of Communities of Environmental Microorganisms   (Colombia)

Author keywords

Drug resistance; Resazurin; Second line drugs; Tuberculosis

Indexed keywords

CAPREOMYCIN; ISONIAZID; KANAMYCIN; OFLOXACIN; RESAZURIN; RIFAMPICIN;

ANALYTICAL EQUIPMENT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BIOASSAY; COLORIMETRIC REDOX INDICATOR; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; EXTENSIVELY DRUG RESISTANT TUBERCULOSIS; GOLD STANDARD; INTERMETHOD COMPARISON; LABORATORY TEST; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; RESAZURIN MICROTITRE ASSAY; SENSITIVITY AND SPECIFICITY; TURNAROUND TIME; VALIDATION STUDY;

ANTITUBERCULAR AGENTS; COLORIMETRY; DRUG RESISTANCE, MULTIPLE, BACTERIAL; EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS; HUMANS; INDICATORS AND REAGENTS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; OXIDATION-REDUCTION;

EID: 79952792505     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkq527     Document Type: Article

References (15)

1. WHO. Multidrug and Extensively Drug-Resistant TB (M/XDR-TB): Global Report on Surveillance and Response. WHO/HTM/TB/2010.3, 2010.
2. WHO. The Global MDR-TB and XDR-TB Response Plan, 2007-2008. WHO/HTM/TB/2007.387, 2007.
3. Canetti G, Froman S, Grosset J et al. Mycobacteria: laboratory methods for testing drug sensitivity and resistance. Bull World Health Organ 1963; 29: 565-78.
4. WHO. Report of the Ninth Meeting of the Strategic and Technical Advisory Group for Tuberculosis (STAG-TB). 2009. http://www.who.int/tb/advisory_bodies/stag/en/index.html (17 November 2010, date last accessed).
5. Martin A, Camacho M, Portaels F et al. Resazurin microtiter assay plate testing of Mycobacterium tuberculosis susceptibilities to second-line drugs: rapid, simple, and inexpensive method. Antimicrob Agents Chemother 2003; 47: 3616-9.
6. National Committee for Clinical Laboratory Standards. Susceptibility Testing of Mycobacteria, Nocardia, and Other Aerobic Actinomycetes-Second Edition: Tentative Standard M24-T2. NCCLS, Wayne, PA, USA, 2000.
7. Jureen P, Werngren J, Hoffner SE. Evaluation of the line probe assay (LiPA) for rapid detection of rifampicin resistance in Mycobacterium tuberculosis. Tuberculosis (Edinb) 2004; 84: 311-6.
8. Kiepiela P, Bishop KS, Smith AN et al. Genomic mutations in the katG, inhA and aphC genes are useful for the prediction of isoniazid resistance in Mycobacterium tuberculosis isolates from Kwazulu Natal, South Africa. Tuber Lung Dis 2000; 80: 47-56.
9. Yew WW, Chan E, Chan CY et al. Genotypic and phenotypic resistance of Mycobacterium tuberculosis to rifamycins and fluoroquinolones. Int J Tuberc Lung Dis 2002; 6: 936-7.
10. Maus CE, Plikaytis BB, Shinnick TM. Molecular analysis of crossresistance to capreomycin, kanamycin, amikacin and viomycin in Mycobacterium tuberculosis. Antimicrob Agents Chemother 2005; 49: 3192-7.
11. National Committee for Clinical Laboratory Standards. Susceptibility Testing of Mycobacteria, Nocardiae, and Other Aerobic Actinomycetes: Approved Standard M24-A. NCCLS, Wayne, PA, USA, 2003.
12. Morcillo N, Di Giulio B, Testani B et al. A microplate indicator-based method for determining the susceptibility of multidrug-resistant Mycobacterium tuberculosis to antimicrobial agents. Int J Tuberc Lung Dis 2004; 28: 253-9.
13. Rodrigues C, Jani J, Shenai S et al. Drug susceptibility testing of Mycobacterium tuberculosis against second-line drugs using the Bactec MGIT 960 system. Int J Tuberc Lung Dis 2008; 12: 1449-55.
14. Rüsch-Gerdes S, Pfyffer GE, Casal M et al. Multicenter laboratory validation of the BACTEC MGIT 960 technique for testing susceptibilities of Mycobacterium tuberculosis to classical second-line drugs and newer antimicrobials. J Clin Microbiol 2006; 44: 688-92.
15. Bwanga F, Joloba ML, Haile M et al. Evaluation of seven tests for the rapid detection of multidrug-resistant tuberculosis in Uganda. Int J Tuberc Lung Dis 2010; 14: 890-5.